Cargando…

Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease

Detalles Bibliográficos
Autores principales:	Taboada, Manuel, Caruezo, Valentín, Naveira, Alberto, Atanassoff, Peter G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247969/ https://www.ncbi.nlm.nih.gov/pubmed/32474331 http://dx.doi.org/10.1016/j.jclinane.2020.109926

Ejemplares similares

Safe percutaneous dilational tracheostomy in 5 patients with ARDS by Covid-19
por: Taboada, Manuel, et al.
Publicado: (2020)

Effectiveness of dexmedetomidine combined with high flow nasal oxygen and long periods of awake prone positioning in moderate or severe COVID-19 pneumonia
por: Taboada, Manuel, et al.
Publicado: (2021)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Prone positioning in awake non-ICU patients with ARDS caused by COVID-19
por: Taboada, Manuel, et al.
Publicado: (2020)

Caution When Comparing the Impact of Corticosteroids in COVID-19
por: Confalonieri, Marco, et al.
Publicado: (2021)

Reply to Lipworth et al.: Inhaled Corticosteroids and COVID-19
por: Maes, Tania, et al.
Publicado: (2020)

Caution against corticosteroid-based COVID-19 treatment
por: Tang, Chong, et al.
Publicado: (2020)

Corticosteroids for COVID-19: the search for an optimum duration of therapy
por: Mishra, Gyanshankar P, et al.
Publicado: (2021)

Real world and hyper reality
por: Gautret, Philippe, et al.
Publicado: (2021)

Corticosteroids and COVID-19: What Could Be the Best Bet in Treating Active Glomerular Diseases in Patients With Concomitant Early COVID-19?
por: Nayak, Saurabh, et al.
Publicado: (2021)

Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
por: Añón, José M., et al.
Publicado: (2021)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply
por: Meduri, G. Umberto, et al.
Publicado: (2021)

High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response
por: López Zúñiga, Miguel Ángel, et al.
Publicado: (2021)

Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
por: Liu, Wang-Da, et al.
Publicado: (2022)

Adjunctive corticosteroid treatment for organizing pneumonia in COVID-19 patients with persistent respiratory failure
por: Segala, Francesco Vladimiro, et al.
Publicado: (2021)

Irinotecan-Induced Serpentine Supravenous Hyper-Pigmentation
por: Gaurav, Vishal, et al.
Publicado: (2022)

Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children
por: Belhadjer, Zahra, et al.
Publicado: (2020)

COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

Erratum: COVID-19–related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids
por: Peters, Michael C.
Publicado: (2020)

Multiple Hypo- and Hyper-Pigmentation: An Example of Twin Spotting?
por: Zhang, Li-Wen, et al.
Publicado: (2022)

Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series
por: Yang, Stephen Su, et al.
Publicado: (2020)

Low frequency of COVID-19 in inflammatory bowel diseases
por: Marafini, Irene, et al.
Publicado: (2020)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Pediatric inflammatory multisystem disease in children with COVID-19
por: Joob, Beuy, et al.
Publicado: (2021)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids()
por: Varona Pérez, J., et al.
Publicado: (2020)

When to call it off: Defining the role of low-dose corticosteroids in thwarting the progression of non-severe COVID-19
por: Almas, Talal, et al.
Publicado: (2021)

Corticosteroids are effective in the treatment of viruspositive post‐COVID myoendocarditis with high autoimmune activity
por: Blagova, Olga, et al.
Publicado: (2023)

Relapse of SARS upon tapering corticosteroid
por: Chien, Jung-Yien, et al.
Publicado: (2004)

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
por: Haberman, Rebecca, et al.
Publicado: (2020)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era
por: Nardone, Olga Maria, et al.
Publicado: (2020)

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
por: An, Ping, et al.
Publicado: (2020)

Analysis of ultrasound clinical early warning system in hyper-coiling umbilical cord
por: Xie, Junshu, et al.
Publicado: (2023)

Critically ill COVID-19 patients attended by anesthesiologists in northwestern Spain: A multicenter prospective observational study()
por: Taboada, M., et al.
Publicado: (2021)

Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches
por: Choi, Hojun, et al.
Publicado: (2022)

Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Pacientes críticos COVID-19 atendidos por anestesiólogos en el Noroeste de España: estudio multicéntrico, prospectivo, observacional
por: Taboada, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gl9mgfa980leveulrff80ufbbm